✦ LIBER ✦

Intensive treatment strategies in patients with high-risk myelodysplastic syndrome and secondary acute myeloid leukemia

✍ Scribed by M. Oosterveld; T. de Witte

Book ID: 111724669
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 98 KB
Volume: 14
Category: Article
ISSN: 0268-960X
DOI: 10.1054/blre.2000.0139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intensive chemotherapy with idarubicin,

Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia

✍ W. K. Hofmann; G. Heil; C. Zander; S. Wiebe; O. G. Ottmann; L. Bergmann; K. Hoef 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 109 KB

Intensive antileukemic treatment of pati

Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia

✍ T. de Witte; P. Muus; B. de Pauw; C. Haanen 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB

Predicting infections in high-risk patie

Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study

✍ Merkel, Drorit; Filanovsky, Kalman; Gafter-Gvili, Anat; Vidal, Liat; Aviv, Ariel 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Unrelated bone marrow transplantation in

✍ Arnold, R; de Witte, T; van Biezen, A; Hermans, J; Jacobsen, N; Runde, V; Gratwo 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 40 KB

183 Results of treatment in patients wit

183 Results of treatment in patients with acute myeloid leukemia preceeded by primary myelodysplastic syndrome

✍ H. Urbańska-Ryś; E. Krykowski; A. Fronczak; A. Wrzesień-Kuś; M. Blasińska-Morawi 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Intensive chemotherapy is not recommende

Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypes

✍ Sabine Knipp; Barbara Hildebrand; Andrea Kündgen; Aristoteles Giagounidis; Guido 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

## Abstract ## BACKGROUND. It is unclear whether intensive chemotherapy is beneficial to patients with high‐risk myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) if they are aged ≥60 years. ## METHODS. The authors studied 160 patients with a median age of 67 years who received inte